IMIDomics Announces Appointment of Key Science and Medical Research Experts to Newly Formed Immunology Advisory Board
SAN RAFAEL, Calif. & BARCELONA--(BUSINESS WIRE)--IMIDomics, Inc., a biotechnology company focused on the discovery and development of new medicines for the treatment of patients with immune-mediated inflammatory diseases (IMIDs), announced today the formation of an Immunology Advisory Board consisting of a number of scientific and industry luminaries with experience in...
